pocketful logo light
pocketful logo light
Hester Biosciences Ltd logo

Hester Biosciences Ltd

NSE: HESTERBIO BSE: 524669

₹2102.20

(0.69%)

Sat, 11 Jul 2026, 02:39 pm

Hester Biosciences Share Price Live Chart

1 Day

(0.69%)

No Result Found

Summary

  • Market Cap (in Cr)

    1702.18

  • Net Profit (in Cr)

    28.83

  • P/B

    3.39

  • Sector P/E

    33.76

  • P/E

    38.81

  • EV/EBITDA

    18.42

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    9.51

  • ROCE

    8.86

  • Debt/Equity

    0.76

  • EPS (TTM)

    62.79

  • Dividend Yield

    0.55

  • Book Value

    423.47

  • Interest Cover

    4.12

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (4.4x coverage).
  • Hester Biosciences's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Hester Biosciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Hester Biosciences is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Hester Biosciences's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Hester Biosciences's level of debt (56.5%) compared to net worth is high (greater than 40%).
  • High level of physical assets or inventory.
  • Rajiv's remuneration is higher than average for companies of similar size in India.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters53.7353.7353.7353.7353.73
FII0.380.510.530.040.87
DII0.000.010.000.020.02
Public45.8945.7545.7446.2045.38
Government00000

Read More

Technical Analysis

RSI

54.16

MACD

54.78

50 DMA

1954.94

200 DMA

1681.88

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2939.972535.172350.532130.371945.731725.571320.77
Fibonacci2535.172380.532285.002130.371975.731880.201725.57
Camarilla2277.222240.112203.012130.372128.792091.692054.58

Pivots Level: Classic

R3

+809.60

2939.97

R2

+404.80

2535.17

R1

+220.17

2350.53

2130.37
2130.37
Pivot Point
LTP: 2120.90

S1

-184.63

1945.73

S2

-404.80

1725.57

S3

-809.60

1320.77

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    2140.91

  • 20-EMA

    2111.74

  • 30-EMA

    2063.53

  • 50-EMA

    1968.39

  • 100-EMA

    1829.62

  • 200-EMA

    1768.92

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
15 May 2026board-meetingsAccounts, Final Dividend
30 Jan 2026board-meetingsQuarterly Results
11 Jul 2025agm
06 Jul 2025dividendFinal Dividend - Rs. - 706 Aug 2025
09 May 2025dividend₹7.00 Dividend /Share06 Aug 2025
26 Jul 2024agm
22 Jul 2024agmAnnual General Meeting23 Aug 2024
22 Jul 2024dividendDividend - Rs 6 Per Share22 Aug 2024
10 May 2024dividend₹6.00 Dividend /Share23 Aug 2024
23 Aug 2023agm

Read More

Peer Comparison

Hester Biosciences Ltd logo

Hester Biosciences Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Hester Biosciences Ltd About

Hester Biosciences is principally engaged in manufacturing of veterinary vaccines and trading of veterinary health products. The Company has two principal operating and reporting segments viz. Poultry healthcare and Animal healthcare.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1987

Headquarters

CEO

Bhupendra V Gandhi

Employees

Contact

Website icon

Website

http://www.hester.in

Email icon

Email

investor@hesterbiosciences.co.in

Phone icon

Phone

91-079-26445107

Location icon

Location

1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006

Read More

Hester Biosciences Ltd Company History

YearHistory
2013
  • Hester Biosciences received WHO GMP Certification.
  • Hester launched Bivalent Marek's Disease Live Vaccine.
2014
  • Hester Biosciences board approved a scheme of amalgamation.
  • The Company recommended a dividend of Rs. 2.00 per equity share of Rs. 10 each for the financial year 2013-14.
2015
  • Hester Biosciences launched PPR vaccine and Goat Pox vaccine.
2020
  • Hester Nepal launched the thermo-tolerant PPR Vaccine.
2021
  • Hester to produce and commercialize Classical Swine Fever Vaccine and Sheep Pox Vaccine.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
HESTER COblockSell90000732.122 Mar 2017
RAJIV DINblockBuy90000732.122 Mar 2017
HESTER COATINGS PRIVATE LIMITEDbulkSell90000732.122 Mar 2017
RAJIV DINESH GANDHIbulkBuy90000732.122 Mar 2017
K PAL JOYbulkSell4780027621 Aug 2014
SHIRIN DHUNJISHAW GHANDHIbulkSell60000171.801 Jul 2014
PIYUSH BATUKBHAI DAVEbulkBuy50000110.2324 Jun 2013
PIYUSH BATUKBHAI DAVEbulkSell50000110.6724 Jun 2013
VIRAJBEN SIDDHARTHBHAI PATELbulkBuy2850512622 Aug 2012
JASHWANT JAGMOHAN SHAHbulkSell2850512622 Aug 2012

Read More

Hester Biosciences Ltd News

Hester Biosciences exits Texas Lifesciences

Hester Biosciences sold its 11% stake in Texas Lifesciences for INR 23 million on July 8, 2026, fully exiting the investment.

09 Jul 2026

companies

Hester Biosciences corrects Executive Director salary

Hester Biosciences corrected the gross salary for Executive Director Ms. Priya Gandhi to INR 10 lakh per month. The 39th AGM is scheduled for 21 July 2026.

08 Jul 2026

companies

Hester Biosciences submits BRSR for FY26

Hester Biosciences filed its Business Responsibility and Sustainability Report for FY26, reporting total energy consumption of 53.09 Tera Joules and Scope 1 and 2 emissions of 8,626 metric tonnes. The company confirmed 100% sourcing from critical suppliers and zero safety incidents during the year.

18 Jun 2026

companies

Hester Biosciences FY26 profit jumps 99%

Consolidated PAT rose 99% to INR 574.84 million in FY26. Revenue grew 7% to INR 3,325.99 million, driven by Poultry Healthcare.

18 Jun 2026

companies

Hester Biosciences AGM on 21 July 2026

Hester Biosciences Limited has scheduled its 39th AGM for 21 July 2026 to approve FY26 results and a dividend of INR 11 per share.

18 Jun 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number